218594-02-6 Usage
General Description
4-BOC-2-MORPHOLINECARBALDEHYDE is a chemical compound with the molecular formula C12H19NO4. It is a derivative of morpholine and is commonly used in organic synthesis as a protective group for amines. The BOC (tert-butoxycarbonyl) group serves as a protecting group for the amine functionality, allowing for selective reactions to occur without interference from the amine group. 4-BOC-2-MORPHOLINECARBALDEHYDE is often used in the production of various pharmaceuticals and other organic compounds due to its ability to control the reactivity of the amine group in organic reactions. Additionally, 4-BOC-2-MORPHOLINECARBALDEHYDE may also have applications in other fields such as material science and cosmetics.
Check Digit Verification of cas no
The CAS Registry Mumber 218594-02-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,8,5,9 and 4 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 218594-02:
(8*2)+(7*1)+(6*8)+(5*5)+(4*9)+(3*4)+(2*0)+(1*2)=146
146 % 10 = 6
So 218594-02-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H17NO4/c1-10(2,3)15-9(13)11-4-5-14-8(6-11)7-12/h7-8H,4-6H2,1-3H3
218594-02-6Relevant articles and documents
5-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY
-
Page/Page column 445, (2021/05/21)
The invention relates to heteroaryl compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.
CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF
-
Page/Page column 90-91, (2009/01/20)
The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonarydiseases like asthma and COPD.